Researchers noted evidence of cartilage repair and potential reduction in surgical need, representing one of the most cited human clinical data points for intra-articular BPC-157 use
Based on KFF analysis of Medicare data from 2020, an estimated 7% of Medicare beneficiaries, or 3.6 million overall, had established cardiovascular disease and obesity or overweight in 2020, and so could be eligible for Medicare coverage of Wegovy for its new indication (Figure 1) (see Methods for details)
GLP-1RAs approved for use in the treatment of T2DM include semaglutide, liraglutide, and dulaglutide
Discovery phase: Once the case is filed, it may enter into the discovery phase
[18] LanCL1 has been identified as a binding and functional mediator of LAT8881 activity in neuropathic-pain models, but its role in adipocyte or whole-body metabolic effects remains unresolved